Neurocrine Biosciences Inc
NBIX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000914475
In the last 90 days, Neurocrine Biosciences Inc insiders filed 0 open-market purchases and 7 sales; 782 institutions reported holding it in 13F filings for Q2 2026, worth $17.0B in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Neurocrine Biosciences Inc as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 782
- +87 vs. Q1 2026
- Shares held
- 101.0M
- +1.44M (+1.5%) vs. Q1 2026
- Total value
- $17.0B
- +$3.91B (+29.9%) vs. Q1 2026
- New holders
- 149
- 320 more added
- Sold out
- 62
- 229 more reduced
5 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NBIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 782 | $17.0B |
| Q1 2026 | 700 | $13.2B |
| Q4 2025 | 733 | $14.1B |
| Q3 2025 | 650 | $13.6B |
| Q2 2025 | 587 | $12.4B |
| Q1 2025 | 587 | $10.6B |
| Q4 2024 | 602 | $12.9B |
| Q3 2024 | 577 | $10.7B |
| Q2 2024 | 595 | $12.9B |
| Q1 2024 | 591 | $12.9B |
| Q4 2023 | 555 | $12.2B |
| Q3 2023 | 513 | $10.4B |
| Q2 2023 | 457 | $8.64B |
| Q1 2023 | 488 | $9.22B |
| Q4 2022 | 530 | $10.7B |
| Q3 2022 | 466 | $9.60B |
| Q2 2022 | 439 | $8.74B |
| Q1 2022 | 426 | $8.45B |
| Q4 2021 | 406 | $7.59B |
| Q3 2021 | 397 | $8.66B |
| Q2 2021 | 409 | $8.89B |
| Q1 2021 | 421 | $9.25B |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Neurocrine Biosciences Inc; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −6,688−100.0% | Sold out |
| Polymer Capital Management (US) LLC | 0 | $0 | 0.00% | −6,290−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −5,789−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −5,793−100.0% | Sold out |
| IMC-Chicago, LLC | 0 | $0 | 0.00% | −4,951−100.0% | Sold out |
| Marex Group plc | 0 | $0 | 0.00% | −4,920−100.0% | Sold out |
| MOKAN Wealth Management Inc. | 0 | $0 | 0.00% | −4,585−100.0% | Sold out |
| AlphaGrep UK Ltd | 0 | $0 | 0.00% | −4,252−100.0% | Sold out |
| Riggs Asset Managment Co. Inc. | 0 | $0 | 0.00% | −3,818−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −3,767−100.0% | Sold out |
| Evoke Wealth, LLC | 0 | $0 | 0.00% | −3,629−100.0% | Sold out |
| RMB Capital Management, LLC | 0 | $0 | 0.00% | −3,327−100.0% | Sold out |
| Farringdon Capital, Ltd. | 0 | $0 | 0.00% | −3,211−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −3,093−100.0% | Sold out |
| Sectoral Asset Management Inc | 0 | $0 | 0.00% | −2,300−100.0% | Sold out |
| GenTrust, LLC | 0 | $0 | 0.00% | −2,541−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| MQS Management LLC | 0 | $0 | 0.00% | −2,471−100.0% | Sold out |
| Osmosis Investment Management UK Ltd | 0 | $0 | 0.00% | −2,228−100.0% | Sold out |
| Metis Global Partners, LLC | 0 | $0 | 0.00% | −2,113−100.0% | Sold out |
| Gallacher Capital Management LLC | 0 | $0 | 0.00% | −1,758−100.0% | Sold out |
| V-Square Quantitative Management LLC | 0 | $0 | 0.00% | −1,711−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −1,671−100.0% | Sold out |
| Westpac Banking Corp | 0 | $0 | 0.00% | −1,615−100.0% | Sold out |
| Banco Bilbao Vizcaya Argentaria, S.A. | 0 | $0 | 0.00% | −1,540−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −1,014−100.0% | Sold out |
| S-Bank Fund Management Ltd | 0 | $0 | 0.00% | −885−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −556−100.0% | Sold out |
| Wealth Preservation Advisors, LLC | 0 | $0 | 0.00% | −402−100.0% | Sold out |
| Golden State Equity Partners | 0 | $0 | 0.00% | −305−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −182−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −212−100.0% | Sold out |
| Twin Peaks Wealth Advisors, LLC | 0 | $0 | 0.00% | −137−100.0% | Sold out |
| RWM Asset Management, LLC | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| Bravera Wealth | 0 | $0 | 0.00% | −84−100.0% | Sold out |
| MJT & Associates Financial Advisory Group, Inc. | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Innovative Asset Advisors Group, LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Lloyd Advisory Services, LLC. | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Legacy Wealth Managment, LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Annis Gardner Whiting Capital Advisors, LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Richardson Capital Management LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Strategic Wealth Partners, Ltd. | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Vermillion Wealth Management, Inc. | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Curio Wealth, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Janus Henderson Group PLC | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |
| Skopos Labs, Inc. | – | – | – | – | Not filed |
| Journey Strategic Wealth LLC | – | – | – | – | Not filed |
| Sunbelt Securities, Inc. | – | – | – | – | Not filed |